Antipsychotics Flashcards
Antipsychotics
Schizophrenia
Bipolar
Psychosis
- Break from reality (distorted or non-existent sense of reality)
- Hallucinations: seeing, hearing feeling things that aren’t there
- Delusions: firm, fixed beliefs that are untrue and seem irrational to others
- Sx of mental illness
Psychotic disorder
Mood disorders with psychotic features
- Bipolar
- Major depression
Substance-induced psychosis
Dementia/delirium with psychotic features
Schizophrenia
Schizoaffective disorder
Antipsychotics
Dopamine hypothesis: overstimulation of DA receptors
- Chlorpromazine: induced state of mental indifference in pts; sedation w/o narcosis
Motivational salience
- Antipsychotics block dopaminergic effects
- Drugs don’t erase delusions by blocking dopamine
- Delusions/hallucinations are dormant
- Normal thoughts also blocked
- Patients report dysphoria
Indications
- Schizophrenia
- Bipolar disorder
- Acute psychosis (mania)
- Major depression with psychotic features
- Severe behavioral problems
- Tourette syndrome (haloperidol)
First Generation Antipsychotics
Haloperidol (Haldol) Fluphenazine (Prolixin) Perphenazine (Trilafon) Thioridazine (Mellaril) Chlorpromazine (Thorazine)
First Generation Antipsychotics MOA
- Don’t get used much due to the blocking of dopamine receptors, causing movement problems
D2 receptor antagonist
- Antipsychotic effects: relief of positive sx (delusions hallucinations, thought disorders, movement disorders)
ADR:
- Induction of EPS: abnormal, involuntary movements (akathisia, dystonia, dyskinesia, pseudoparkinsonism)
- Increased prolactin levels (lacrimation/ breast development)
5HT2c receptor antagnoist
- ADR: contributes to wt gain
Alpha 1 antagonist
- ADR: sedation
H1 antagonist
- ADR: sedation, wt gain
M1 antagonist
- ADR: anticholinergic effects (urinary retention, constipation, dry mouth, blurred vision, confusion)
First generation ADRs
- Movement disorder (dystonia, bradykinesia, tremor, akathisia, choreoathertosis)
- Anhedonia
- Sedation
- Wt gain
- Temperature dysregulation
- Hyperprolactinemia (galactorrhea/ amenorrhea)
- Postural hypotension
- Sunburn
- Prolonged QT
Second generation (Atypical) antipsychotics
Aripiprazole (Abilify) Brexpiprazole (Rexulti) Asenapine Maleate (Saphris) Clozapine (Clozaril) Iloperidone (Fanapt) Lurasidone (Latuda) Olanzapine (Zyprexa) Paliperidone (Invega) Quetiapine (Seroquel) Risperidone (Risperdal) Ziprasidone (Geodon)
Second Generation Antipsychotics MOA
- Antipsychotic effects w/o the extrapyramidal sx
- Helps with negative sx: apathy, social withdrawal, decreased motivation, cognitive impairment
D2 receptor antagonist
5HT1 receptor agonist: antidepressant/anxiolytic
5HT2A antagonist: negative sx improvement
5HT2c receptor antagonist
Alpha 1 antagonist
H1 antagonist
M1 antagonist
Second generation ADR
- DM
- Hypercholesterolemia
- Sedation
- Moderate movement disorder
- Hypotension
Risperidone
- Hyperprolactinemia
Olanzapine
- Wt gain
Clozapine
- Seizures
- Nocturnal salivation
- Agranulocytosis
- Myocarditis
- Lens opacities
- Wt gain
Avoiding second generation ADR best choices
Sedation
- W/O: Aripiprazole, Iloperidone, Lurasidone
- W/: Clozapine
Wt Gain
- W/O: Aripiprazole, Lurasidone, Ziprasidone
- W/: Clozapine
EPS
- W/O: Clozapine, Iloperidone, Quetiapine
- w/ Paliperidone
Antipsychotic black box
- Increased mortality in eldery pts with dementia related psychosis
- Causes varied: CV (heart failure, sudden death); Infection (pneumonia)
Aripiprazole
- Schizophrenia
- Bipolar disorder (monotherapy or adjunctive to Li or valproate)
- Adjunct treatment of major depressive disorder
- Irritability associated with autistic disorder
- Acute treatment of agitation
Brexpiprazole (Rexulti)
- Schizophrenia, adjunct for MDD
- WARNING: increased mortality and CVA in elderly dementia pts with psychosis, tardive dyskinesia, NMS
- Hyperglycemia, hyperlipidemia, wt gain, blood dyscrasias, akathisia, somnolence, anxiety, restlessness
Asenapine (Saphris)
- Acute treatment of manic or mixed episodes associated with bipolar I disorder in adults (monotherapy or adjunctive therapy with either Li or valproate)
- Acute and maintenance treatment of schizophrenia in adults
- MOA: DA, 5HT, NE, H1 receptor antagonist
- ADR: Insomnia, somnolence, N/V, anxiety, agitation, HA, constipation, psychosis; same warning as iloperidone